Matches in Nanopublications for { ?s ?p "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646630.RAP11erNGu4rObKEykJh14j-wWpdw8vYPc6naBP0uXy1I130_provenance.
- NP296159.RAmBDgoMRPaLl81jL-Is-JpuXHAXqQaVTJp20zSi5D0wU130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296159.RAmBDgoMRPaLl81jL-Is-JpuXHAXqQaVTJp20zSi5D0wU130_provenance.
- NP1311505.RAVYqweW0Vwe4kP2YSdQGsvWrPXE2nS_DEjY1xrQLfd0A130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311505.RAVYqweW0Vwe4kP2YSdQGsvWrPXE2nS_DEjY1xrQLfd0A130_provenance.
- NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311506.RAfUl6I4Ow5fhLJgsd4SSdvjmkplrNGjPqJ9txR8fQ8SQ130_provenance.
- NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_assertion description "[Among the investigated CD44 splice variants expression of exon v6 is the most promising prognostic marker in surgically treated cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295665.RAw2d8jPvUnpoGgKWyCICFGcP7WvmG0c1hjAYEMMBIFGo130_provenance.